Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WGRX
WGRX logo

WGRX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.115
Open
0.101
VWAP
0.10
Vol
3.63M
Mkt Cap
10.11M
Low
0.095
Amount
371.01K
EV/EBITDA(TTM)
--
Total Shares
104.87M
EV
33.93M
EV/OCF(TTM)
--
P/S(TTM)
0.30
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Show More

Events Timeline

(ET)
2026-03-23
09:30:00
Wellgistics Health Signs LOI to Acquire Neuritek Therapeutics
select
2026-03-19 (ET)
2026-03-19
09:00:00
Wellgistics Health President Converts $2 Million Compensation to Stock
select
2026-03-13 (ET)
2026-03-13
09:20:00
Wellgistics Transitions to Online Prescription Drug Seller
select
2026-03-11 (ET)
2026-03-11
08:50:00
Wellgistics Health Secures Preferred Pricing Rights for Medical Insurance
select
2026-03-09 (ET)
2026-03-09
07:50:00
Wellgistics Health Launches Forzet Medical Food
select
2026-03-05 (ET)
2026-03-05
07:50:00
Wellgistics Health Selects Blockchain Platforms for Pharmacy Tracking System
select
2026-02-23 (ET)
2026-02-23
08:50:00
Datavault AI and Wellgistics Health Expand Blockchain Partnership
select
2026-02-18 (ET)
2026-02-18
07:50:00
Wellgistics Health Completes Strategic Investment in Mental Health AI Startup
select
2026-02-11 (ET)
2026-02-11
07:40:00
Wellgistics Health Expands Partnership with Tollo Health
select
2026-02-09 (ET)
2026-02-09
09:00:00
Wellgistics Health Partners with NFL Alumni Health to Launch Wellness Programs
select

News

seekingalpha
8.5
03-23seekingalpha
Wellgistics Health Plans $105M Acquisition of Neuritek Therapeutics
  • Acquisition Intent: Wellgistics Health (WGRX) has signed a non-binding letter of intent to pursue a potential all-stock acquisition of Neuritek Therapeutics valued at $105 million, aiming to enhance its healthcare platform by adding research capabilities.
  • Transaction Conditions: The deal is subject to due diligence, negotiation of definitive agreements, board approvals, and other customary conditions, indicating uncertainty in the acquisition process and potential hurdles ahead.
  • Strategic Expansion: Wellgistics is also evaluating additional strategic opportunities, including acquisitions and partnerships, as part of its broader growth strategy, demonstrating the company's proactive approach to future development.
  • Market Reaction: Following the announcement, WGRX's stock price surged 21.89% in premarket trading to $0.167, reflecting positive market sentiment regarding the acquisition plan.
NASDAQ.COM
7.5
03-12NASDAQ.COM
Wellgistics Health Enhances PharmacyChain Platform with EBV Pricing
  • Core Functionality Enhancement: Wellgistics Health strengthens its PharmacyChain platform with newly secured preferred pricing for medical insurance eligibility and benefits verification (EBV), which is expected to accelerate adoption across its provider, partner, and pharmacy network.
  • Instant Confirmation Capability: The EBV feature allows pharmacies and healthcare organizations to instantly confirm whether a patient's insurance covers a specific product or service and at what level, thereby enhancing the efficiency of modern health technology workflows.
  • Revenue Potential: Wellgistics' preferred pricing is positioned to reduce costs for its network while opening a new revenue stream, with EBV expected to become a meaningful contributor to revenue starting in the second quarter of 2026.
  • Market Outlook: The EBV market is projected to grow from $2.39 billion in 2025 to $3 billion by 2030, reflecting trends of increasing billing complexity and higher claim denial rates, with Wellgistics aiming to address these challenges through its PharmacyChain technology infrastructure.
Benzinga
9.5
03-12Benzinga
Petco Reports Strong Q4 Results, Shares Surge
  • Performance Beat: Petco Health and Wellness reported Q4 revenue of $1.515 billion, surpassing analyst expectations of $1.513 billion, indicating strong market performance despite missing profit forecasts.
  • Loss Details: The company reported a quarterly loss of 1 cent per share, falling short of the expected earnings of 2 cents per share, yet the revenue growth suggests improvements in sales and customer engagement.
  • Stock Reaction: Petco's shares surged 12.1% to $2.69 in pre-market trading, reflecting investor optimism about the company's future growth potential, which may attract more investor interest.
  • Market Trends: The stock price increase following the earnings report could influence overall investment sentiment in the pet industry, especially against a backdrop of rising consumer spending, indicating potential recovery in the sector.
seekingalpha
7.5
02-18seekingalpha
Wellgistics Health Completes Strategic Investment in AI Mental Health Startup
  • Strategic Investment Completed: Wellgistics Health (WGRX) announced the completion of a strategic investment in a San Francisco-based mental health AI startup, aiming to expand its footprint in the mental health software market, which is projected to enhance the company's market share in this rapidly growing sector.
  • Partnership Reinforcement: This investment not only strengthens the partnership with Tollo Health but also supports collaboration with NFL Alumni Health, indicating a growing strategic focus on mental health that aims to enhance patient service quality through technological innovation.
  • Patient Engagement Enhancement: Wellgistics is increasing its focus on patient engagement to improve prescription drug compliance and support patients initiating GLP-1 drug treatments, planning to achieve this through digital tools integrated with its pharmacy network, thereby enhancing the patient treatment experience.
  • Market Growth Potential: The company cited industry data projecting the mental health software market to grow from $6.3 billion in 2025 to $18.1 billion by 2033, highlighting the significant growth potential in this field, which further drives Wellgistics' strategic investment decisions.
Benzinga
9.5
2025-11-26Benzinga
Autodesk Shares Rise Approximately 6%; 20 Stocks Making Moves in Premarket Trading
  • Autodesk's Strong Performance: Autodesk Inc reported third-quarter results with adjusted EPS of $2.67 and revenue of $1.85 billion, both exceeding analyst expectations, leading to a 6.1% increase in share price during pre-market trading.

  • Other Notable Gainers: Mobile-Health Network Solutions surged 45.4%, Inno Holdings gained 29.5%, and KALA Bio increased by 24.1% in pre-market trading, driven by various positive developments and agreements.

  • Significant Losers: Nutanix Inc saw a 16.8% drop after disappointing financial results and lowered sales guidance, while Biomx Inc and Kaixin Holdings also experienced notable declines of 13.2% and 12.1%, respectively.

  • Market Overview: The pre-market trading session showed mixed results, with several companies like Urban Outfitters and Petco Health and Wellness reporting better-than-expected earnings, while others faced declines due to poor financial performance.

Benzinga
8.5
2025-10-27Benzinga
Avidity Biosciences Stock Rises Approximately 42%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Avidity Biosciences Acquisition: Avidity Biosciences Inc. shares surged after Novartis AG announced its acquisition of the company for $72.00 per share, a 46% premium over Avidity's closing price on October 24.

  • Pre-Market Trading Highlights: Several stocks saw significant gains in pre-market trading, including Click Holdings Limited (+173%), Treasure Global Inc (+52.4%), and Banco BBVA Argentina SA (+31.3%).

  • Notable Stock Declines: Picard Medical, Inc. experienced a sharp decline of 65.3%, while Genenta Science SPA and Wellgistics Health Inc. also saw significant drops of 32.3% and 31.5%, respectively.

  • Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting both gainers and losers, along with their respective percentage changes.

Valuation Metrics

The current forward P/E ratio for Wellgistics Health Inc (WGRX.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Wellgistics Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks low float high volume today
Intellectia · 2933 candidates
Relative Vol: >= 1.50Floating Shares: <= 50,000,000
Ticker
Name
Market Cap$
top bottom
MGRX logo
MGRX
Mangoceuticals Inc
2.64M
TOVX logo
TOVX
Theriva Biologics Inc
8.89M
WNW logo
WNW
Meiwu Technology Co Ltd
2.33M
UGRO logo
UGRO
urban-gro Inc
1.64M
HKIT logo
HKIT
Hitek Global Inc
34.87M
LNKS logo
LNKS
Linkers Industries Ltd
9.31M
stocks under $1 that will be bullish today
Intellectia · 96 candidates
Price: <= $1.00
Ticker
Name
Market Cap$
top bottom
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
SAFX logo
SAFX
XCF Global Inc
28.75M
MKDW logo
MKDW
MKDWELL Tech Inc
14.59M
SRXH logo
SRXH
Srx Health Solutions Inc
11.89M
ADIL logo
ADIL
Adial Pharmaceuticals Inc
6.04M
GRI logo
GRI
GRI Bio Inc
2.26M
stovks to buy on wed from 20 to 40 cents
Intellectia · 81 candidates
Price: $0.20 - $0.40
Ticker
Name
Market Cap$
top bottom
SGMO logo
SGMO
Sangamo Therapeutics Inc
127.97M
IXHL logo
IXHL
Incannex Healthcare Inc
123.43M
GPUS logo
GPUS
Hyperscale Data Inc
96.48M
AURE logo
AURE
Aurelion Inc
95.26M
AIIO logo
AIIO
Robo.ai Inc
89.22M
ZONE logo
ZONE
CleanCore Solutions Inc
79.36M

Whales Holding WGRX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Wellgistics Health Inc (WGRX) stock price today?

The current price of WGRX is 0.0964 USD — it has decreased -4

What is Wellgistics Health Inc (WGRX)'s business?

Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.

What is the price predicton of WGRX Stock?

Wall Street analysts forecast WGRX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for WGRX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Wellgistics Health Inc (WGRX)'s revenue for the last quarter?

Wellgistics Health Inc revenue for the last quarter amounts to 1.67M USD, decreased -86.54

What is Wellgistics Health Inc (WGRX)'s earnings per share (EPS) for the last quarter?

Wellgistics Health Inc. EPS for the last quarter amounts to -0.29 USD, increased 123.08

How many employees does Wellgistics Health Inc (WGRX). have?

Wellgistics Health Inc (WGRX) has 13 emplpoyees as of April 01 2026.

What is Wellgistics Health Inc (WGRX) market cap?

Today WGRX has the market capitalization of 10.11M USD.